KA00.9

ICD-11 MMS 2026-01

Fetus or newborn affected by maternal chemotherapy

Coding note from above levels

These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth). Use additional code to identify the condition in the fetus or newborn.

Conditions arising in the perinatal period, even though death or morbidity occurs later, should, as far as possible, be coded to chapter 19, which takes precedence over chapters containing codes for diseases by their anatomical site. For children less than 28 days old, assume that a reported condition developed in the perinatal period, unless the duration is stated and the onset was after the first completed week of life.

Index terms

  • Fetus or newborn affected by maternal chemotherapy

Exclusions from above levels

  • http://id.who.int/icd/entity/1004987305 – fetus and newborn affected by maternal endocrine and metabolic disorders
  • KA01 – Fetus or newborn affected by maternal complications of pregnancy
  • KA06 – Fetus or newborn affected by noxious influences transmitted via placenta or breast milk
Show allHide
  • 01 – Certain infectious or parasitic diseases - acquired after birth
  • 02 – Neoplasms
  • 05 – Endocrine, nutritional or metabolic diseases
  • 08 – Certain congenital diseases of the nervous system
  • 20 – Congenital malformations, deformations and chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes
  • 3A10 – Hereditary haemolytic anaemia
  • 4A01.03 – Transient hypogammaglobulinaemia of infancy
  • 9B71.3 – Retinopathy of prematurity
  • BC43 – congenital cardiomyopathy
  • DA93.0 – Paralytic ileus
  • EA50.Z – Pemphigus neonatorum
  • EH40.00 – Cradle cap
  • http://id.who.int/icd/entity/588616678 – Gastroenteritis or colitis of infectious origin
  • http://id.who.int/icd/entity/609214049 – Congenital gonococcal infection

Sibling codes

  • KA00.0 – Fetus or newborn affected by maternal hypertensive disorders
  • KA00.1 – Fetus or newborn affected by gestational oedema or proteinuria without hypertension
  • KA00.2 – Fetus or newborn affected by maternal renal or urinary tract diseases
  • KA00.3 – Fetus or newborn affected by maternal infectious diseases
  • KA00.4 – Fetus or newborn affected by periodontal disease in mother
  • KA00.5 – Fetus or newborn affected by maternal respiratory diseases
  • KA00.6 – Fetus or newborn affected by maternal nutritional disorders
  • KA00.7 – Fetus or newborn affected by abnormal maternal chemistry
  • KA00.8 – Fetus or newborn affected by maternal injury
  • KA00.A – Fetus or newborn affected by surgical procedure on mother
  • KA00.B – Fetus or newborn affected by maternal anaemia
  • KA00.Y – Fetus or newborn affected by other specified maternal condition that may be unrelated to present pregnancy
  • KA00.Z – Fetus or newborn affected by unspecified maternal condition that may be unrelated to present pregnancy

Foundation entity

Fetus or newborn affected by maternal chemotherapy – http://id.who.int/icd/entity/697492429

Part of: KA00: Fetus or newborn affected by maternal conditions that may be unrelated to present pregnancy › 19: Certain conditions originating in the perinatal period